TY - JOUR
T1 - Frequent loss of heterozygosity at telomeric loci on 22q in sporadic colorectal cancers
AU - Yana, Ikuo
AU - Kurahashi, Hiroki
AU - Nakamori, Shoji
AU - Kameyama, Masao
AU - Nakamura, Tsutomu
AU - Takami, Motohisa
AU - Mori, Takesada
AU - Takai, Shinichiro
AU - Nishisho, Isamu
PY - 1995/1/17
Y1 - 1995/1/17
N2 - To date, several tumor‐suppressor genes responsible for the tumorigenesis of colorectal cancer have been identified. However, studies of loss of heterozygosity (LOH) have suggested several chromosomal regions which may contain additional tumor‐suppressor genes for colorectal cancer. To determine the extent and variation of allelic loss on 22q, on which LOH has been frequently observed, a total of 68 sporadic colorectal cancers was examined for LOH on the chromosome arm by means of 16 polymorphic DNA markers. LOH was observed in 28 tumors (41 %), of which 9 showed LOH at all informative loci. The remaining 19 tumors showed variable patterns of partial loss on 22q, delimiting the smallest region of overlap (SRO) between D22S90 and D22S94. Moreover, LOH within the SRO correlated with a progression in terms of Dukes' stages. These results suggest that an additional tumor‐suppressor gene for colorectal cancer may exist on 22q distally to the NF2 locus and that inactivation of the gene may possibly play a role in the progression or metastasis of colorectal cancers. © 1995 Wiley‐Liss, Inc.
AB - To date, several tumor‐suppressor genes responsible for the tumorigenesis of colorectal cancer have been identified. However, studies of loss of heterozygosity (LOH) have suggested several chromosomal regions which may contain additional tumor‐suppressor genes for colorectal cancer. To determine the extent and variation of allelic loss on 22q, on which LOH has been frequently observed, a total of 68 sporadic colorectal cancers was examined for LOH on the chromosome arm by means of 16 polymorphic DNA markers. LOH was observed in 28 tumors (41 %), of which 9 showed LOH at all informative loci. The remaining 19 tumors showed variable patterns of partial loss on 22q, delimiting the smallest region of overlap (SRO) between D22S90 and D22S94. Moreover, LOH within the SRO correlated with a progression in terms of Dukes' stages. These results suggest that an additional tumor‐suppressor gene for colorectal cancer may exist on 22q distally to the NF2 locus and that inactivation of the gene may possibly play a role in the progression or metastasis of colorectal cancers. © 1995 Wiley‐Liss, Inc.
UR - http://www.scopus.com/inward/record.url?scp=0028936598&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028936598&partnerID=8YFLogxK
U2 - 10.1002/ijc.2910600207
DO - 10.1002/ijc.2910600207
M3 - Article
C2 - 7829211
AN - SCOPUS:0028936598
SN - 0020-7136
VL - 60
SP - 174
EP - 177
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 2
ER -